Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
VMAR - Vision Marine Technologies Inc - Stock Price Chart
TickerVMAR [NASD]
CompanyVision Marine Technologies Inc
CountryCanada
IndustryRecreational Vehicles
Market Cap5.27MEPS (ttm)-114.37
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.43EPS next 5Y-
P/B1.22EPS Q/Q-116.34%
Dividend-Sales Q/Q-85.67%
Insider Own-Inst Own0.17%
Insider Trans0.00%Inst Trans-9.28%
Short Float-EarningsDec 02/b
Analyst Recom1.00Target Price2741.41
Avg Volume555.15K52W Range4.04 - 1039.50
Vision Marine Technologies, Inc. engages in the design, development, and manufacturing of electric outboard powertrain systems and electric boats. It operates through the Sale of Electric Boats and Rental of Electric Boats segments. The Sale of Electric Boats segment involves the manufacture of customized boats for the consumer market, sale of parts, and maintenance. The Rental of electric boats segment includes short-term rental operations and boat club membership. The company was founded by Patrick Bobby and Alexander Mongeon in 1995 and is headquartered in Boisbriand, Canada.
MNPR - Monopar Therapeutics Inc - Stock Price Chart
TickerMNPR [NASD]
CompanyMonopar Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap235.51MEPS (ttm)-4.12
P/E-EPS this Y54.16%
Forward P/E-EPS next Y-88.78%
PEG-EPS past 5Y-15.56%
P/S-EPS next 5Y81.75%
P/B4.27EPS Q/Q-351.80%
Dividend-Sales Q/Q-
Insider Own35.63%Inst Own42.18%
Insider Trans0.07%Inst Trans2.55%
Short Float1.29%EarningsMar 31/b
Analyst Recom1.40Target Price56.00
Avg Volume51.26K52W Range1.72 - 54.30
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tactic Pharma LLC10% OwnerApr 02 '25Proposed Sale35.0033,3341,166,806Apr 02 11:45 AM
Radhakrishnan KarthikChief Financial OfficerOct 28 '24Buy16.251,55025,1881,550Oct 30 04:17 PM
Cittadine AndrewChief Operating OfficerJun 20 '24Buy0.7420,50815,254186,132Jun 21 05:16 PM
Cittadine AndrewChief Operating OfficerJun 18 '24Buy0.8612,00010,320165,624Jun 21 05:16 PM
Cittadine AndrewChief Operating OfficerJun 14 '24Buy0.9312,00011,176141,624Jun 17 06:08 PM
AUID - authID Inc - Stock Price Chart
TickerAUID [NASD]
CompanyauthID Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap60.28MEPS (ttm)-1.46
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.64%
P/S67.73EPS next 5Y-
P/B5.24EPS Q/Q-42.66%
Dividend-Sales Q/Q177.81%
Insider Own15.94%Inst Own15.47%
Insider Trans0.57%Inst Trans8.65%
Short Float3.46%EarningsMar 13/a
Analyst Recom-Target Price-
Avg Volume76.01K52W Range4.01 - 12.31
authID, Inc. engages in the delivery of secure, mobile, and biometric identity solutions. It operates through the Verified Authentication Business segment. The company was founded by Thomas R Snoke on September 21, 2011 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Szoke Thomas RobertChief Technology OfficerDec 11 '24Sale6.341,0006,34015,518Dec 12 08:00 AM
Szoke Thomas RobertChief Technology OfficerDec 10 '24Sale6.301,0006,30016,518Dec 12 08:00 AM
Thompson Michael CharlesDirectorDec 10 '24Buy6.495,00032,46283,677Dec 11 08:05 AM
Szoke Thomas RobertChief Technology OfficerDec 06 '24Sale6.251,5009,38117,518Dec 10 05:27 PM
Jisser KenDirectorDec 09 '24Buy6.488,00051,84051,475Dec 10 08:01 AM
HAO - Haoxi Health Technology Ltd - Stock Price Chart
TickerHAO [NASD]
CompanyHaoxi Health Technology Ltd
CountryChina
IndustryAdvertising Agencies
Market Cap23.67MEPS (ttm)0.04
P/E32.28EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.49EPS next 5Y-
P/B3.49EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own90.43%Inst Own0.44%
Insider Trans0.00%Inst Trans52.64%
Short Float3.18%Earnings-
Analyst Recom-Target Price-
Avg Volume166.95K52W Range0.84 - 265.00
Haoxi Health Technology Ltd. is a holding company, which engages in the provision of internet marketing solutions. It offers services for various industries to reduce risks, reduce operating costs, and ensure greater profits through in-depth insights into strategy, creativity, media integration, and industry development. The company was founded on August 5, 2022 and is headquartered in Beijing, China.
DMN - Damon Inc - Stock Price Chart
TickerDMN [NASD]
CompanyDamon Inc
CountryCanada
IndustryAuto Manufacturers
Market Cap0.43MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own19.98%Inst Own86.87%
Insider Trans0.00%Inst Trans10.61%
Short Float15.16%Earnings-
Analyst Recom-Target Price-
Avg Volume46.59M52W Range- - 4.95
Damon, Inc. operates as a holding company that provides data analytics and statistical visualization solutions. The company was founded on October 17, 2023 and is headquartered in Vancouver, Canada.
KPTI - Karyopharm Therapeutics Inc - Stock Price Chart
TickerKPTI [NASD]
CompanyKaryopharm Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap34.17MEPS (ttm)-15.34
P/E-EPS this Y-2.81%
Forward P/E-EPS next Y33.42%
PEG-EPS past 5Y27.91%
P/S0.24EPS next 5Y27.89%
P/B-EPS Q/Q32.92%
Dividend-Sales Q/Q-9.50%
Insider Own6.75%Inst Own48.33%
Insider Trans-8.09%Inst Trans-4.86%
Short Float13.62%EarningsFeb 19/b
Analyst Recom1.57Target Price48.93
Avg Volume107.90K52W Range3.51 - 23.40
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cheng Sohanya RoshanEVP & Chief Commercial OfficerMar 04 '25Sale6.293,44521,66934,314Mar 06 04:27 PM
Paulson Richard A.President and CEOMar 04 '25Sale6.2911,69473,55582,984Mar 06 04:27 PM
Rangwala ReshmaEVP & Chief Medical OfficerMar 04 '25Sale6.293,58722,56229,272Mar 06 04:26 PM
Poulton StuartEVP, Chief Development OfficerMar 04 '25Sale6.293,54822,31727,414Mar 06 04:24 PM
Mano MichaelSVP, General Counsel&SecretaryMar 04 '25Sale6.292,79317,56821,047Mar 06 04:13 PM
GLTO - Galecto Inc - Stock Price Chart
TickerGLTO [NASD]
CompanyGalecto Inc
CountryUSA
IndustryBiotechnology
Market Cap4.27MEPS (ttm)-18.59
P/E-EPS this Y21.75%
Forward P/E-EPS next Y-34.28%
PEG-EPS past 5Y14.83%
P/S-EPS next 5Y-17.40%
P/B0.29EPS Q/Q12.50%
Dividend-Sales Q/Q-
Insider Own13.48%Inst Own3.19%
Insider Trans-1.15%Inst Trans11.40%
Short Float2.43%EarningsMar 19/a
Analyst Recom2.00Target Price8.00
Avg Volume247.73K52W Range2.79 - 19.75
Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jorgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgard Schambye in 2011 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Winslow GarrettGeneral CounselJan 03 '25Sale5.604712,6381,009Jan 07 04:00 PM
Firmani LoriInterim CFOJan 03 '25Sale5.632611,469465Jan 07 04:00 PM
Schambye Hans T.Chief Executive OfficerJan 03 '25Sale5.601,3417,5103,397Jan 07 04:00 PM
JUNE - Junee Ltd - Stock Price Chart
TickerJUNE [NASD]
CompanyJunee Ltd
CountrySingapore
IndustryEngineering & Construction
Market Cap140.31MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-50.17%
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own82.48%Inst Own0.35%
Insider Trans0.00%Inst Trans-28.17%
Short Float0.40%Earnings-
Analyst Recom-Target Price-
Avg Volume42.88K52W Range2.75 - 9.90
Junee Ltd. operates as a holding company which provides interior design and fit-out services. It offers design, fit out and repair and maintenance services for commercial and residential buildings. The firm's interior design services include preliminary consulting services, conceptualizing clients design ideas with layout plans, and producing detailed design drawings. Its Fit-out services include activities making an interior space suitable for residential or commercial purposes. The company was founded on August 25, 2021, and is headquartered in Hong Kong.
PTHL - Pheton Holdings Ltd - Stock Price Chart
TickerPTHL [NASD]
CompanyPheton Holdings Ltd
CountryChina
IndustryMedical Devices
Market Cap55.58MEPS (ttm)-0.05
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S123.50EPS next 5Y-
P/B8.99EPS Q/Q-141.28%
Dividend-Sales Q/Q-34.30%
Insider Own78.25%Inst Own0.11%
Insider Trans0.00%Inst Trans-89.89%
Short Float1.83%Earnings-
Analyst Recom-Target Price-
Avg Volume71.53K52W Range1.32 - 6.45
Mar-17-25 08:31AM Why Pheton Holdings Ltd. (PTHL) Soared Last Week? (Insider Monkey) -12.20%
Sep-06-24 04:08PM Pheton Holdings Ltd Announces Closing of Initial Public Offering (GlobeNewswire) -9.23%
Sep-05-24 09:31AM Pheton Holdings Ltd Announces Pricing of Initial Public Offering (GlobeNewswire)
Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.
PVLA - Palvella Therapeutics Inc - Stock Price Chart
TickerPVLA [NASD]
CompanyPalvella Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap297.17MEPS (ttm)-12.61
P/E-EPS this Y73.58%
Forward P/E-EPS next Y-15.47%
PEG-EPS past 5Y11.57%
P/S220.13EPS next 5Y21.21%
P/B2.19EPS Q/Q74.87%
Dividend-Sales Q/Q-100.00%
Insider Own40.39%Inst Own19.79%
Insider Trans0.09%Inst Trans4.60%
Short Float0.60%EarningsMar 31/b
Analyst Recom1.00Target Price49.25
Avg Volume63.16K52W Range6.20 - 29.27
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JENKINS GEORGE MDirectorDec 18 '24Buy12.934,00051,720180,671Dec 19 10:23 AM
GERAGHTY JAMES ADirectorAug 07 '24Buy1.00111Oct 28 05:18 PM
ADAR1 Capital Management, LLC10% OwnerAug 12 '24Buy15.883,00047,647129,574Aug 12 06:48 PM
ADAR1 Capital Management, LLC10% OwnerAug 09 '24Buy14.893,00044,679127,331Aug 12 06:48 PM
1234567891020